Skip to main content

Main menu

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

Current concepts: host–pathogen interactions in cystic fibrosis airways disease

Anthony C. Tang, Stuart E. Turvey, Marco P. Alves, Nicolas Regamey, Burkhard Tümmler, Dominik Hartl
European Respiratory Review 2014 23: 320-332; DOI: 10.1183/09059180.00006113
Anthony C. Tang
1Dept of Pediatrics, British Columbia Children’s Hospital, Vancouver, British Columbia, Canada. 2Child and Family Research Institute, University of British Columbia, Vancouver, British Columbia, Canada. 3Division of Pediatric Respiratory Medicine, University Hospital, Bern, Switzerland. 4Clinical Research Group, Clinic for Pediatric Pneumology, Allergology and Neonatology, Hanover Medical School, Hanover, Germany. 5Cystic Fibrosis Research Group, Dept of Pediatrics I, University of Tübingen, Tübingen, Germany. 6Both authors contributed equally.
1Dept of Pediatrics, British Columbia Children’s Hospital, Vancouver, British Columbia, Canada. 2Child and Family Research Institute, University of British Columbia, Vancouver, British Columbia, Canada. 3Division of Pediatric Respiratory Medicine, University Hospital, Bern, Switzerland. 4Clinical Research Group, Clinic for Pediatric Pneumology, Allergology and Neonatology, Hanover Medical School, Hanover, Germany. 5Cystic Fibrosis Research Group, Dept of Pediatrics I, University of Tübingen, Tübingen, Germany. 6Both authors contributed equally.
1Dept of Pediatrics, British Columbia Children’s Hospital, Vancouver, British Columbia, Canada. 2Child and Family Research Institute, University of British Columbia, Vancouver, British Columbia, Canada. 3Division of Pediatric Respiratory Medicine, University Hospital, Bern, Switzerland. 4Clinical Research Group, Clinic for Pediatric Pneumology, Allergology and Neonatology, Hanover Medical School, Hanover, Germany. 5Cystic Fibrosis Research Group, Dept of Pediatrics I, University of Tübingen, Tübingen, Germany. 6Both authors contributed equally.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stuart E. Turvey
1Dept of Pediatrics, British Columbia Children’s Hospital, Vancouver, British Columbia, Canada. 2Child and Family Research Institute, University of British Columbia, Vancouver, British Columbia, Canada. 3Division of Pediatric Respiratory Medicine, University Hospital, Bern, Switzerland. 4Clinical Research Group, Clinic for Pediatric Pneumology, Allergology and Neonatology, Hanover Medical School, Hanover, Germany. 5Cystic Fibrosis Research Group, Dept of Pediatrics I, University of Tübingen, Tübingen, Germany. 6Both authors contributed equally.
1Dept of Pediatrics, British Columbia Children’s Hospital, Vancouver, British Columbia, Canada. 2Child and Family Research Institute, University of British Columbia, Vancouver, British Columbia, Canada. 3Division of Pediatric Respiratory Medicine, University Hospital, Bern, Switzerland. 4Clinical Research Group, Clinic for Pediatric Pneumology, Allergology and Neonatology, Hanover Medical School, Hanover, Germany. 5Cystic Fibrosis Research Group, Dept of Pediatrics I, University of Tübingen, Tübingen, Germany. 6Both authors contributed equally.
1Dept of Pediatrics, British Columbia Children’s Hospital, Vancouver, British Columbia, Canada. 2Child and Family Research Institute, University of British Columbia, Vancouver, British Columbia, Canada. 3Division of Pediatric Respiratory Medicine, University Hospital, Bern, Switzerland. 4Clinical Research Group, Clinic for Pediatric Pneumology, Allergology and Neonatology, Hanover Medical School, Hanover, Germany. 5Cystic Fibrosis Research Group, Dept of Pediatrics I, University of Tübingen, Tübingen, Germany. 6Both authors contributed equally.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marco P. Alves
1Dept of Pediatrics, British Columbia Children’s Hospital, Vancouver, British Columbia, Canada. 2Child and Family Research Institute, University of British Columbia, Vancouver, British Columbia, Canada. 3Division of Pediatric Respiratory Medicine, University Hospital, Bern, Switzerland. 4Clinical Research Group, Clinic for Pediatric Pneumology, Allergology and Neonatology, Hanover Medical School, Hanover, Germany. 5Cystic Fibrosis Research Group, Dept of Pediatrics I, University of Tübingen, Tübingen, Germany. 6Both authors contributed equally.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicolas Regamey
1Dept of Pediatrics, British Columbia Children’s Hospital, Vancouver, British Columbia, Canada. 2Child and Family Research Institute, University of British Columbia, Vancouver, British Columbia, Canada. 3Division of Pediatric Respiratory Medicine, University Hospital, Bern, Switzerland. 4Clinical Research Group, Clinic for Pediatric Pneumology, Allergology and Neonatology, Hanover Medical School, Hanover, Germany. 5Cystic Fibrosis Research Group, Dept of Pediatrics I, University of Tübingen, Tübingen, Germany. 6Both authors contributed equally.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Burkhard Tümmler
1Dept of Pediatrics, British Columbia Children’s Hospital, Vancouver, British Columbia, Canada. 2Child and Family Research Institute, University of British Columbia, Vancouver, British Columbia, Canada. 3Division of Pediatric Respiratory Medicine, University Hospital, Bern, Switzerland. 4Clinical Research Group, Clinic for Pediatric Pneumology, Allergology and Neonatology, Hanover Medical School, Hanover, Germany. 5Cystic Fibrosis Research Group, Dept of Pediatrics I, University of Tübingen, Tübingen, Germany. 6Both authors contributed equally.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dominik Hartl
1Dept of Pediatrics, British Columbia Children’s Hospital, Vancouver, British Columbia, Canada. 2Child and Family Research Institute, University of British Columbia, Vancouver, British Columbia, Canada. 3Division of Pediatric Respiratory Medicine, University Hospital, Bern, Switzerland. 4Clinical Research Group, Clinic for Pediatric Pneumology, Allergology and Neonatology, Hanover Medical School, Hanover, Germany. 5Cystic Fibrosis Research Group, Dept of Pediatrics I, University of Tübingen, Tübingen, Germany. 6Both authors contributed equally.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Dominik.Hartl@med.uni-tuebingen.de
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Chronic infection and inflammation are defining characteristics of cystic fibrosis (CF) airway disease. Conditions within the airways of patients living with CF are conducive to colonisation by a variety of opportunistic bacterial, viral and fungal pathogens. Improved molecular identification of microorganisms has begun to emphasise the polymicrobial nature of infections in the CF airway microenvironment. Changes to CF airway physiology through loss of cystic fibrosis transmembrane conductance regulator functionality result in a wide range of immune dysfunctions, which permit pathogen colonisation and persistence. This review will summarise the current understanding of how CF pathogens infect, interact with and evade the CF host.

Footnotes

  • Support statement: This work was supported by funding from Cystic Fibrosis Canada. S.E. Turvey holds the Aubrey J. Tingle Professorship in Pediatric Immunology and is a clinical scholar of the Michael Smith Foundation for Health Research.

  • Conflict of interest: Disclosures can be found alongside the online version of this article at err.ersjournals.com

  • Provenance: Submitted article, peer reviewed.

  • Received August 29, 2013.
  • Accepted October 7, 2013.
  • ©ERS 2014

ERR articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.

View Full Text
PreviousNext
Back to top
View this article with LENS
Vol 23 Issue 133 Table of Contents
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Current concepts: host–pathogen interactions in cystic fibrosis airways disease
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Current concepts: host–pathogen interactions in cystic fibrosis airways disease
Anthony C. Tang, Stuart E. Turvey, Marco P. Alves, Nicolas Regamey, Burkhard Tümmler, Dominik Hartl
European Respiratory Review Sep 2014, 23 (133) 320-332; DOI: 10.1183/09059180.00006113

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Current concepts: host–pathogen interactions in cystic fibrosis airways disease
Anthony C. Tang, Stuart E. Turvey, Marco P. Alves, Nicolas Regamey, Burkhard Tümmler, Dominik Hartl
European Respiratory Review Sep 2014, 23 (133) 320-332; DOI: 10.1183/09059180.00006113
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Introduction
    • The CF lung microenvironment
    • Infection in CF
    • The inflammatory consequences of dysfunctional immune mechanisms in CF: the example of modifier genes
    • Infections in CF and non-CF lung disease
    • Conclusions and future directions
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • CF and non-CF bronchiectasis
  • Epidemiology, occupational and environmental lung disease
  • Respiratory infections and tuberculosis
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Effects of CPAP therapy on glucose metabolism in patients with OSA and type 2 diabetes
  • Unsupervised home spirometry versus supervised clinic spirometry for respiratory disease
  • Peripheral blood monocyte count and outcomes in patients with ILD
Show more Reviews

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERR

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising
  • Sponsorship

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN: 0905-9180
Online ISSN: 1600-0617

Copyright © 2023 by the European Respiratory Society